Table 2
Annual Benefits for CDSS Elements at Brigham and Women's Hospital
| CDSS Element | Total Benefits |
| Renal dosing guidance | 2.24 |
| ADE prevention | 1.05 |
| Nurse time utilization | 0.96 |
| Specific or expensive drug guidance (human growth hormone, vancomycin, ceftriaxone, ondansetron, histamine-2 receptor blockers) | 0.88 |
| ADE monitor | 0.76 |
| Intravenous to oral guidance | 0.74 |
| Laboratory charge display and redundant laboratory warnings | 0.34 |
| Panic laboratory alerting | 0.34 |
| Radiology indications, rule-out, and assistant | 0.15 |
| Automated medication summary at hospital discharge | 0.10 |
| Physician time utilization | 0.10 |
| Elderly dosing guidance | 0.05 |
| Specific drug level guidance (antiepileptics, rheumatologic tests) | 0.02 |
-
This table depicts the annual benefits (in 2002 millions of dollars) for each element of CDSS at Brigham and Women's Hospital given an 80% prospective reimbursement rate.
